• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of Commercial Investigational New Drugs Applications (INDs)/Investigational Drug Exemptions (IDEs) received in the month (1)

Dictionary: This measure shows the number of commercial, research, and emergency INDs / IDEs received in the month. An IND / IDE application is submitted to the FDA to request permission to conduct U.S. clinical trials using investigational products. Commercial INDs / IDEs reflect new products under development. Research INDs / IDEs reflect work that supports research and public health initiatives. Emergency INDs are requests to FDA, generally made by telephone, for an investigational drug to be used for the treatment of an individual patient by a licensed physician.

Information is current as of September 30, 2012

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetNumber
Oct 2010N/A7
Nov 2010N/A10
Dec 2010N/A8
Jan 2011N/A10
Feb 2011N/A8
Mar 2011N/A5
Apr 2011N/A12
May 2011N/A5
Jun 2011N/A5
Jul 2011N/A12
Aug 2011N/A8
Sep 2011N/A9

FY 2011 Total: 99

Footnotes

  • (1) Tracking against these measures did not start until July 2010

Number of Research IND/IDEs received in the month (1)

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetNumber
Oct 2010N/A14
Nov 2010N/A10
Dec 2010N/A12
Jan 2011N/A9
Feb 2011N/A11
Mar 2011N/A16
Apr 2011N/A21
May 2011N/A11
Jun 2011N/A10
Jul 2011N/A16
Aug 2011N/A15
Sep 2011N/A27

FY 2011 Total: 172

Number of Emergency IND/IDEs received in the month (1)

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetNumber
Oct 2010N/A1
Nov 2010N/A3
Dec 2010N/A1
Jan 2011N/A2
Feb 2011N/A1
Mar 2011N/A2
Apr 2011N/A4
May 2011N/A0
Jun 2011N/A0
Jul 2011N/A1
Aug 2011N/A1
Sep 2011N/A1

FY 2011 Total: 17

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.